May 4, 2017 / 7:17 PM / in 7 months

BRIEF-Alk-Abello says co's Acarizax has been approved in Canada

May 4 (Reuters) - Alk-abello A/S :

* Co’s house dust mite sublingual allergy immunotherapy tablet, Acarizax has been approved in Canada Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below